Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 4:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–28 of 4 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Chronic Kidney Disease; Iron Deficiency Anemia Clear all

Terminated Phase 3 Interventional Results available

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

NCT01155375

View directory record Official record

Conditions: Iron Deficiency Anemia
Interventions: Ferumoxytol, Oral Iron; Drug
Lead sponsor: AMAG Pharmaceuticals, Inc.; Industry
Eligibility: 6 Months to 17 Years

Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Waltham, Massachusetts

Source: ClinicalTrials.gov public record

Updated Apr 3, 2022 · Synced May 22, 2026, 4:18 AM EDT

Completed Phase 4 Interventional

Effect of Two Iron Preparations on Protein in the Urine

NCT00354692

View directory record Official record

Conditions: Kidney Failure, Chronic, Anemia, Iron-Deficiency
Interventions: Sodium Ferric Gluconate and Iron sucrose; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years and older

Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 2
States / cities: Glendale, California • Shreveport, Louisiana

Source: ClinicalTrials.gov public record

Updated Aug 13, 2012 · Synced May 22, 2026, 4:18 AM EDT

Completed Phase 3 Interventional Results available

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

NCT02940860

View directory record Official record

Conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia, Chronic Kidney Disease
Interventions: Iron isomaltoside/ferric derisomaltose, Iron sucrose; Drug
Lead sponsor: Pharmacosmos A/S; Industry
Eligibility: 18 Years and older

Enrollment: 1,538 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 141
States / cities: Huntsville, Alabama • Little Rock, Arkansas • Chula Vista, California + 96 more

Source: ClinicalTrials.gov public record

Updated Oct 5, 2020 · Synced May 22, 2026, 4:18 AM EDT

Completed Phase 2 Interventional Results available

Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis

NCT01736397

View directory record Official record

Conditions: Iron Deficiency, Iron Deficiency Anemia
Interventions: Ferric Citrate, Placebo; Drug
Lead sponsor: Keryx Biopharmaceuticals; Industry
Eligibility: 18 Years and older

Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 20
States / cities: Tempe, Arizona • La Mesa, California • Sacramento, California + 17 more

Source: ClinicalTrials.gov public record

Updated Oct 19, 2017 · Synced May 22, 2026, 4:18 AM EDT